Related Experiment Video
Updated: Jul 21, 2025

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
Predictors of TB disease in HIV-exposed children from Southern Africa
E R Maritz1, G Montepiedra2, C D Mitchell3
1Family Center for Research with Ubuntu, Department of Paediatrics & Child Health, Stellenbosch University, Cape Town, South Africa.
Insights
Low weight-for-age Z-score (WAZ) and high viral load (VL) predict tuberculosis (TB) or death in HIV-positive children. Antiretroviral therapy (ART) and increasing CD4% are protective factors.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- The P1041 trial investigated isoniazid prophylaxis in South Africa.
- This study focuses on identifying predictors of tuberculosis (TB) in HIV-exposed children within the P1041 trial.
Purpose of the Study:
- To identify predictors of TB incidence in HIV-positive and HIV-exposed uninfected children.
- To evaluate the impact of various factors including housing, overcrowding, and biomarkers on TB risk.
Main Methods:
- Analysis of data from 543 HIV-positive (HIV+) and 808 HIV-exposed uninfected (HEU) infants up to 108 weeks.
- Considered predictors: housing, overcrowding, age, sex, ethnicity, tobacco exposure, weight-for-age Z-score (WAZ), CD4%, viral load (VL), antiretroviral therapy (ART), and household smoking.
Main Results:
- In HIV+ children, low WAZ and high VL were significant TB predictors. Higher CD4% and ART were protective.
- In HEU children, univariate analysis suggested smoking exposure reduced TB-free survival, but this was not significant in multivariate analysis.
Conclusions:
- Low WAZ and high VL are strong predictors of TB disease or death in HIV-exposed children.
- ART initiation and rising CD4% demonstrate protective effects in HIV-positive children.
Abstract:
BACKGROUND: P1041 was a randomised, placebo-controlled isoniazid prophylaxis trial in South Africa. We studied predictors for TB in HIV-exposed children participating in the P1041 trial.METHODS: We included data from entry until Week 108. Predictors considered were type of housing, overcrowding, age, sex, ethnicity, tobacco exposure, weight-for-age percentile Z-score (WAZ), CD4%, viral load (VL), antiretroviral therapy (ART) and number of household smokers.RESULTS: Of 543 HIV-positive (HIV+) and 808 HIV-exposed uninfected (HEU) infants at entry, median age was 96 days (interquartile range: 92-105). Of 1,351 caregivers, 125 (9%) had a smoking history, and 62/1,351 reported current smoking. In 594/1,351 (44%) households, there was at least one smoker. Smoking caregivers consumed 1-5 cigarettes daily. In the HIV+ cohort, significant baseline TB predictors after adjusting covariates were as follows: WAZ (adjusted hazard ratio [aHR] 0.76, P = 0.002) and log10 HIV RNA copies/ml (aHR 1.50, P = 0.009). Higher CD4% (aHR 0.88, P = 0.002) and ART (aHR 0.50, P = 0.006) were protective. In the HEU cohort, smoking exposure was associated with reduced TB-free survival on univariate analysis, but not after adjustment in the multivariate model.CONCLUSION: Low WAZ and high VL were strong predictors of TB disease or death. Rising CD4 percentage and being on ART were protective in the HIV+ cohort.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

